How big is the enzyme-linked immunosorbent assay (ELISA) testing market?

The global enzyme-linked immunosorbent assay (ELISA) testing market size was valued at USD 2.13 billion in 2023 and is predicted to reach USD 4.19 billion by the end of 2034, representing impressive CAGR of 6.32% during the forecast period 2024 to 2034. Read More

What is the CAGR of enzyme-linked immunosorbent assay (ELISA) testing market?

The global enzyme-linked immunosorbent assay (ELISA) testing market is representing impressive CAGR of 6.32% during the forecast period 2024 to 2034. Read More

Which are the driving growth factors of enzyme-linked immunosorbent assay (ELISA) testing market?

Factors such as growingincidence of infectious disorders such as hepatitis, dengue, and AIDS, increasing prevalence of neurological disorders, growing geriatric population, high research and development expenditure of major players, growing per capita healthcare spending, growing incidence of non-communicable diseases, and emergence of cost-effective technologies are driving the growth of enzyme-linked immunosorbent assay (ELISA) testingmarket.Increasing focus on laboratory automation and growing R&D activities in monoclonal antibodies (mABs) and biomarkers are further propelling the enzyme-linked immunosorbent assay (ELISA) testingmarket expansion across the globe. The most important advantage of using ELISA is its specificity and sensitivity with antibodies that are customized for a spec Read More

In 2023, how much is the market share of north america region in the ELISA testing market?

In 2023, North America dominated the global market with a market share of more than 42%. Read More

How much is the CAGr of Asia Pacific region in the ELISA testing market?

The Asia Pacific region is projected to lead with highest CAGR of about 7.8% in the estimate duration majorly because of high frequency of infectious ailments.African, Latin American, and Middle Eastern region will display perceptible progress. Read More

Which major companies are operating in the ELISA testing market?

The major companies operating in the worldwide enzyme-linked immunosorbent assay (ELISA) test market are ZEUS Scientific, Inc., Thermo Fisher Scientific, Inc., R&D Systems, Inc., American Laboratory Products Company (ALPCO), Bio-Rad Laboratories, Inc., BD, BioMérieux SA, and Ortho Clinical Diagnostics, among others. Read More

What is Enzyme-Linked Immunosorbent Assay (ELISA)?

Enzyme-Linked Immunosorbent Assay (ELISA) also named enzyme immunoassay (EIA) is a plate-based assay procedure for discovery and evaluation of substances such as antibodies, hormones, proteins, etc. The ELISA has been employed widely as a significant diagnostic instrument in plant pathology, medicine, as well as a quality-control audit in biotech and pharmaceutical industries. ELISA assay procedure is based on precise antigen antibody attachment. The antigen, to be evaluated, is immobilized on a solid surface and then is complexed with antibody which is linked to an enzyme. Recognition is accomplished by measuring the coupled enzyme activity via incubation with a substrate to manufacture a product that can be calculated. ELISA has usage in various domains such as allergen recognition in th Read More

Enzyme-Linked Immunosorbent Assay Testing Market Size, Share, and Trends 2024 to 2034

The global enzyme-linked immunosorbent assay (ELISA) testing market size was USD 2.13 billion in 2023, estimated at USD 2.27 billion in 2024 and is anticipated to reach around USD 4.19 billion by 2034, expanding at a CAGR of 6.32% from 2024 to 2034.

Last Updated : September 2024
Report Code : 1260
Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, By Test Type

7.1. Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, by Test Type, 2024-2034

7.1.1. Sandwich ELISA

7.1.1.1. Market Revenue and Forecast (2021-2034)

7.1.2. Indirect ELISA

7.1.2.1. Market Revenue and Forecast (2021-2034)

7.1.3. Multiple and Portable ELISA

7.1.3.1. Market Revenue and Forecast (2021-2034)

7.1.4. Competitive ELISA

7.1.4.1. Market Revenue and Forecast (2021-2034)

7.1.5. Others

7.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, By Application

8.1. Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, by Application, 2024-2034

8.1.1. Immunology

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Inflammation

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Infectious diseases

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Cancer

8.1.4.1. Market Revenue and Forecast (2021-2034)

8.1.5. Protein quantification

8.1.5.1. Market Revenue and Forecast (2021-2034)

8.1.6. Other Applications

8.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Test (2021-2034)

9.1.2. Market Revenue and Forecast, by Application (2021-2034)

9.1.3. U.S.

9.1.3.1. Market Revenue and Forecast, by Test (2021-2034)

9.1.3.2. Market Revenue and Forecast, by Application (2021-2034)

9.1.4. Rest of North America

9.1.4.1. Market Revenue and Forecast, by Test (2021-2034)

9.1.4.2. Market Revenue and Forecast, by Application (2021-2034)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Test (2021-2034)

9.2.2. Market Revenue and Forecast, by Application (2021-2034)

9.2.3. UK

9.2.3.1. Market Revenue and Forecast, by Test (2021-2034)

9.2.3.2. Market Revenue and Forecast, by Application (2021-2034)

9.2.4. Germany

9.2.4.1. Market Revenue and Forecast, by Test (2021-2034)

9.2.4.2. Market Revenue and Forecast, by Application (2021-2034)

9.2.5. France

9.2.5.1. Market Revenue and Forecast, by Test (2021-2034)

9.2.5.2. Market Revenue and Forecast, by Application (2021-2034)

9.2.6. Rest of Europe

9.2.6.1. Market Revenue and Forecast, by Test (2021-2034)

9.2.6.2. Market Revenue and Forecast, by Application (2021-2034)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Test (2021-2034)

9.3.2. Market Revenue and Forecast, by Application (2021-2034)

9.3.3. India

9.3.3.1. Market Revenue and Forecast, by Test (2021-2034)

9.3.3.2. Market Revenue and Forecast, by Application (2021-2034)

9.3.4. China

9.3.4.1. Market Revenue and Forecast, by Test (2021-2034)

9.3.4.2. Market Revenue and Forecast, by Application (2021-2034)

9.3.5. Japan

9.3.5.1. Market Revenue and Forecast, by Test (2021-2034)

9.3.5.2. Market Revenue and Forecast, by Application (2021-2034)

9.3.6. Rest of APAC

9.3.6.1. Market Revenue and Forecast, by Test (2021-2034)

9.3.6.2. Market Revenue and Forecast, by Application (2021-2034)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Test (2021-2034)

9.4.2. Market Revenue and Forecast, by Application (2021-2034)

9.4.3. GCC

9.4.3.1. Market Revenue and Forecast, by Test (2021-2034)

9.4.3.2. Market Revenue and Forecast, by Application (2021-2034)

9.4.4. North Africa

9.4.4.1. Market Revenue and Forecast, by Test (2021-2034)

9.4.4.2. Market Revenue and Forecast, by Application (2021-2034)

9.4.5. South Africa

9.4.5.1. Market Revenue and Forecast, by Test (2021-2034)

9.4.5.2. Market Revenue and Forecast, by Application (2021-2034)

9.4.6. Rest of MEA

9.4.6.1. Market Revenue and Forecast, by Test (2021-2034)

9.4.6.2. Market Revenue and Forecast, by Application (2021-2034)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Test (2021-2034)

9.5.2. Market Revenue and Forecast, by Application (2021-2034)

9.5.3. Brazil

9.5.3.1. Market Revenue and Forecast, by Test (2021-2034)

9.5.3.2. Market Revenue and Forecast, by Application (2021-2034)

9.5.4. Rest of LATAM

9.5.4.1. Market Revenue and Forecast, by Test (2021-2034)

9.5.4.2. Market Revenue and Forecast, by Application (2021-2034)

Chapter 10. Company Profiles

10.1. Thermo Fisher Scientific, Inc.

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. American Laboratory Products Company (ALPCO)

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Bio-Rad Laboratories, Inc.

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. BD

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. BioMérieux SA

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Ortho Clinical Diagnostics

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. R&D Systems, Inc.

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. ZEUS Scientific, Inc.

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

We use cookies to improve your experience

Enzyme-Linked Immunosorbent Assay Testing Market Report 2034

List of Contents